No, that doesn’t mean they’ll have children smoking joints in a lab…
The American Academy of Pediatrics (AAP) – a group that focuses on the health of children – this week called on the federal government to deschedule marijuana to do more research studies on the drug. In a new paper, the AAP outlines the idea to loosen restrictions so further research can be done on marijuana’s medicinal use, particularly when it comes to children who are terminally ill where more traditional methods cease to being effective.
Now before proponents for marijuana legalization start pumping their fists Tiger Woods style, it’s important to know that the AAP still opposes legalizing medical marijuana outside the traditional federal process (such as what states like Colorado have done making it legal under state law, but still illegal under federal statutes). With more-and-more research claiming pot use can be problematic to adolescent development, it doesn’t look as if the AAP will be changing their stance on the matter any time soon.
As for the loosening on the restrictions on marijuana research, you’re dealing head-on with the federal bureaucracy. That means red tape.
The amount of work that it would take to loosen marijuana research restrictions – Vox gets weirdly detailed into the process here – is almost herculean in nature. Due to the 1970 Controlled Substance Act, the number of agencies that would be involved includes the US Drug Enforcement Agency, the Department of Health and Human Services, the Food and Drug Association, and the general public through a petition process!
If we were to be frank, a lot of this has to do with how marijuana is viewed by the federal government and people like this.
Currently marijuana, as a Schedule 1 substance, is related to heroin, LSD, ecstasy, and shrooms under government classification. Until that changes, which is an entire boondoggle all its own, research on medicinal marijuana use will remain restricted.
(Photo Credit: Google Images)